| Report ID |
35768 |
| Drug Identification Number |
02212277 |
| Brand name |
CEFTIN - TAB 250MG |
| Common or Proper name |
cefuroxime axetil tablets |
| Company Name |
GLAXOSMITHKLINE INC |
| Market Status |
CANCELLED POST MARKET |
| Active Ingredient(s) |
CEFUROXIME |
| Strength(s) |
250MG |
| Dosage form(s) |
TABLET |
| Route of administration |
ORAL |
| Packaging size |
60's |
| ATC code |
J01DC |
| ATC description |
OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage |
Disruption of the manufacture of the drug. |
| Anticipated start date |
|
| Actual start date |
2018-01-11 |
| Estimated end date |
Unknown |
| Actual end date |
2020-07-20 |
| Shortage status |
Resolved |
| Updated date |
2020-07-24 |
| Company comments |
product has been discontinued. |
| Health Canada comments |
|
| Tier 3 Status |
No |
| Company contact information |
1-800-387-7374 |
